Trial Profile
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Mar 2019
Price :
$35
*
At a glance
- Drugs Staphylococcus aureus vaccine (Primary)
- Indications Staphylococcal infections
- Focus Adverse reactions; First in man; Pharmacodynamics
- Sponsors Pfizer
- 25 Apr 2017 Results (n=440) of this and one other study presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases.
- 01 Dec 2016 Results published in the Vaccine.
- 30 Oct 2016 Results of this and other study presented at the IDWeek 2016.